Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank7
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-403.36M
↓ 47% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-274.44M
Historical baseline
PeriodValueYoY Change
TTM$-403.36M-2.0%
2024$-395.28M+14.2%
2023$-460.56M-15.5%
2022$-398.88M-16.4%
2021$-342.70M-30.8%
2020$-261.94M-26.6%
2019$-206.87M-61.3%
2018$-128.26M-38.1%
2017$-92.88M-73.2%
2016$-53.64M-